Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore Program Sylvia Paz B. Ramirez, Stephen I-Hong Hsu, William.

Slides:

Advertisements

Similar presentations

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Advertisements

Stephen P. McDonald, Graeme R. Russ Kidney International

Chronic Pain in End-Stage Renal Disease

MariLia Bahiense Oliveira, Joao Egidio Romao, Roberto Zatz

Renal manifestations in Fabry disease and therapeutic options

Anemia management in chronic kidney disease

Volume 83, Issue 3, Pages (March 2013)

From secondary to primary prevention of progressive renal disease: The case for screening for albuminuria Paul E. De Jong, Barry M. Brenner Kidney International

Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007 Joanna M. Smith, Susan A. Mott,

Progression of renal failure and hypertensive nephrosclerosis

Burden of chronic kidney disease: North Africa

Haiyan Wang, Luxia Zhang, Jicheng Lv Kidney International

Francesco Paolo Schena Kidney International

Need for better diabetes treatment for improved renal outcome

Chronic Pain in End-Stage Renal Disease

Volume 70, Pages S21-S25 (December 2006)

George A. Kaysen, Burl R. Don

Volume 63, Issue 2, Pages (February 2003)

Comorbidity and confounding in end-stage renal disease

D. Batlle, P. Ramadugu, M.J. Soler Kidney International

Volume 74, Issue 3, Pages (August 2008)

Volume 70, Issue 11, Pages (December 2006)

The epidemiology of chronic kidney disease

Prevention of renal failure: The Malaysian experience

Study of Heart and Renal Protection (SHARP)

Late referral and modality choice in end-stage renal disease

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Fructose intake as a risk factor for kidney stone disease

Volume 68, Pages S4-S10 (August 2005)

New insights in uremic toxins

The third World Kidney Day: Looking back and thinking forward

Volume 17, Issue 2, Pages (February 1950)

Alfonso M. Cueto-Manzano, Héctor R

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Elevated risk of stroke among patients with end-stage renal disease

Nephrology in Latin America, with special emphasis on Brazil

AGEs in foods: Do they play a role in uremia?

Atrial fibrillation in end-stage renal disease: an emerging problem

Lynda Anne Szczech, Ira L. Lazar Kidney International

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Prehypertension: is it relevant for nephrologists?

Homocysteine, renal function, and risk of cardiovascular disease

Volume 62, Issue 3, Pages (September 2002)

Stephen P. McDonald, Graeme R. Russ Kidney International

Opportunities for a chronic disease outreach program in China

ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: The African American Study of Kidney Disease and Hypertension (AASK) trial

Peritoneal dialysis in Mexico

Clinical benefits of slowing the progression of renal failure

Organ transplantation goes to the movies

Volume 55, Pages S3-S16 (June 1999)

Early detection and prevention of diabetic nephropathy: A challenge calling for mandatory action for Mexico and the developing world Ricardo Correa-Rotter,

Is it the low-protein diet or simply the salt restriction?

Charles A. Herzog Kidney International

Is complement a target for therapy in renal disease?

Volume 62, Pages S68-S72 (December 2002)

Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller

James B. Young, Hans-Hellmut Neumayer, Robert D. Gordon

The conundrum of increased burden of end-stage renal disease in Asians

Volume 70, Issue 10, Pages (November 2006)

Volume 69, Issue 8, Pages (April 2006)

Renal vascular disease in the elderly

Familial phenotype differences in PKD11

Morphology of the heart and arteries in renal failure

Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease? Danilo Fliser, Jan T. Kielstein, Hermann Haller, Stefanie M. Bode-Böger Kidney.

Stephen Pastan, J. Michael Soucie, William M. McClellan

The Ebf1 knockout mouse and glomerular maturation

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Presentation transcript:

Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore Program Sylvia Paz B. Ramirez, Stephen I-Hong Hsu, William McClellan Kidney International Volume 63, Pages S61-S65 (February 2003) DOI: 10.1046/j.1523-1755.63.s83.13.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 A framework for a public health approach to prevention. Each boxed area corresponds to specific programs of the NKFS. Points A and B correspond to the Primary Prevention and Early Detection Programs, points C and D correspond to the Secondary Prevention and Intervention Programs. Kidney International 2003 63, S61-S65DOI: (10.1046/j.1523-1755.63.s83.13.x) Copyright © 2003 International Society of Nephrology Terms and Conditions